Author： Williams-Gray Caroline H. Foltynie Thomas Lewis Simon J.G. Barker Roger A.
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.20, Iss.6, 2006-01, pp. : 477-505
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
By Lemay S. Chouinard S. Blanchet P. Masson H. Soland V. Beuter A. Bedard M.-A.
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. :
Pimavanserin for the treatment of Parkinson's disease psychosis
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 14, 2013-10 ,pp. :
Treatment of Psychosis in Parkinsons Disease: Safety Considerations
By Fernandez H.H. Trieschmann M.E. Friedman J.H.
Drug Safety, Vol. 26, Iss. 9, 2003-01 ,pp. :